3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Myelodysplastic Syndromes
15
Hematologic Neoplasms
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Lymphoma, Non-Hodgkin
6
Neuroblastoma
5
Leukemia, Biphenotypic, Acute
5
Myeloproliferative Disorders
4
Graft vs Host Disease
4
Multiple Myeloma
3
Medulloblastoma
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia
3
Hodgkin Disease
3
Ganglioneuroblastoma
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Lymphoma
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Anemia, Refractory, with Excess of Blasts
2
Teratoma
1
Sarcoma, Myeloid
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Pinealoma
1
Neurofibrosarcoma
1
Interventions
pembrolizumab
69
Nivolumab
69
cabozantinib
45
Ipilimumab
38
Specimen Handling
33
Magnetic Resonance Spectroscopy
33
lenvatinib
26
Axitinib
25
belzutifan
21
Sunitinib
18
Biopsy
15
Radiosurgery
14
CTLA-4 Antigen
13
atezolizumab
12
Everolimus
10
pazopanib
8
fludarabine
8
avelumab
8
Bevacizumab
8
toripalimab
7
cemiplimab
7
Nephrectomy
7
Immunoglobulin G
7
Cyclophosphamide
7
aldesleukin
6
Standard of Care
6
Radiotherapy
6
Blood Specimen Collection
6
spartalizumab
5
palbociclib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Thiotepa
×
1 year
×
Clear all
No trials found.